Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/bjd/ljae432
PubMed Identifier: 39506538
Publication URI: http://europepmc.org/abstract/MED/39506538
Type: Journal Article/Review
Parent Publication: The British journal of dermatology
ISSN: 0007-0963